Insight to Combat Post COVID-19 Mortality: Complications and their Biomarkers

被引:0
|
作者
Srivastava, Rajnish [1 ]
Patel, Pankaj Singh [2 ]
Dev, Suresh Kumar [3 ]
Pradhan, Joohee [2 ]
Panchawat, Sunita [2 ]
机构
[1] Moradabad Educ Trust Grp Inst, Fac Pharm, Moradabad, Uttar Pradesh, India
[2] Mohanlal Sukhadia Univ, Dept Pharmaceut Sci, Udaipur, Rajasthan, India
[3] Pacific Acad Higher Educ & Res Univ, Pacific Coll Pharm, Udaipur, Rajasthan, India
关键词
COVID-19; molecular pathogenesis; biomarker; pulmonary mucormycosis; pulmonary fibrosis; pulmonary aspergillosis; INVASIVE PULMONARY ASPERGILLOSIS; PATHOLOGICAL FINDINGS; CYTOKINE STORM;
D O I
10.2174/1566524022666220812111830
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background COVID-19 is a severe acute respiratory syndrome that has become a prominent source of morbidity and mortality around the world. With millions infected globally by the COVID-19 epidemic, long-term care for COVID-19 survivors has become a global concern. As a result, research into the long-term pulmonary and extrapulmonary consequences and complications of COVID is absolutely necessary. Objectives In an attempt to better understand and mitigate post recovery mortality, early detection of the post recovery complication might prevent the severity of the complication and can be recovered. As per cases reported, post covid extrapulmonary complications were more than pulmonary complications. However, the post covid pulmonary complications were found to be more lethal and nonrecoverable in most of the cases than extrapulmonary complications. Methods The present review is an attempt to reveal the role and importance of biomarkers associated with critical post covid pulmonary complications. COVID-19 is associated with post-covid pulmonary fibrosis, pulmonary endothelial dysfunction, pulmonary aspergillosis, pulmonary mucormycosis, biomarkers and WHO, as keywords were used to retrieve updated information. PubMed, and Google Scholar were used as search engines for this. Results There must be a better knowledge of the post-COVID-19 pulmonary problems in terms of systemic pathophysiological results to create multidisciplinary clinics to address both long-term symptoms and potential long-term consequences. This can be achieved by revealing the molecular pathogenesis that can be validated by certain biomarkers and various diagnostic techniques. Accordingly, the clinical program can be designed to treat and effectively manage the post covid pulmonary complications in early-stage to prevent mortality. Conclusion In order to deal with the specific logistical problems given by pandemic circumstances, effective interdisciplinary collaboration models draw on experiences learned during the early phases of the pandemic.
引用
收藏
页码:712 / 725
页数:14
相关论文
共 50 条
  • [1] Post COVID-19 complications and follow up biomarkers
    Abdullah, Muhammad
    Ali, Amjed
    Usman, Muhammad
    Naz, Anam
    Qureshi, Javed Anver
    Bajaber, Majed A.
    Zhang, Xiao
    NANOSCALE ADVANCES, 2023, 5 (21): : 5705 - 5716
  • [2] Myocardial Injury Biomarkers and Cardiac Complications Associated with Mortality in Patients with COVID-19
    Martins-Filho, Paulo Ricardo
    Soares Barreto-Filho, Jose Augusto
    Santos, Victor Santana
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 115 (02) : 273 - 277
  • [3] Utility of biomarkers in predicting complications and in-hospital mortality in patients with COVID-19
    Ali, Noman
    Kapadia, Nazir Najeeb
    Aymen, Dure
    Baig, Noor
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (05)
  • [4] Post COVID-19 medical complications
    Zaidi, Asfia
    Ahmad, Iffat Zareen
    Khan, Elhan
    Tabassum, Heena
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2021, 10 : 63 - 70
  • [5] Cardiac biomarkers and mortality in COVID-19 infection
    Cimino, Giuliana
    Cersosimo, Angelica
    Amore, Ludovica
    Pascariello, Greta
    Pancaldi, Edoardo
    Alghisi, Fabio
    Calvi, Emiliano
    Bernardi, Nicola
    Inciardi, Riccardo Maria
    Lombardi, Carlo Mario
    Vizzardi, Enrico
    Raddino, Riccardo
    Metra, Marco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G87 - +
  • [6] Cardiac biomarkers and mortality in COVID-19 infection
    Cimino, Giuliana
    Cersosimo, Angelica
    Amore, Ludovica
    Pascariello, Greta
    Pancaldi, Edoardo
    Alghisi, Fabio
    Calvi, Emiliano
    Bernardi, Nicola
    Inciardi, Riccardo Maria
    Lombardi, Carlo Mario
    Vizzardi, Enrico
    Raddino, Riccardo
    Metra, Marco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [7] Investigating Biomarkers for COVID-19 Morbidity and Mortality
    Ceci, Flavio Maria
    Ferraguti, Giampiero
    Lucarelli, Marco
    Angeloni, Antonio
    Bonci, Enea
    Petrella, Carla
    Francati, Silvia
    Barbato, Christian
    Di Certo, Maria Grazia
    Gabanella, Francesca
    Gavaruzzi, Francesca
    Mastroianni, Claudio Maria
    Minni, Antonio
    Greco, Antonio
    Ralli, Massimo
    Ceccanti, Mauro
    Tarani, Luigi
    Fiore, Marco
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (13) : 1196 - 1210
  • [8] Predictive Role of Biomarkers in COVID-19 Mortality
    Yilmaz, Ayse
    Taskin, Oeztuerk
    Demir, Ufuk
    Soylu, Veysel G.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [9] Revisiting the COVID-19 Pandemic: An Insight into Long-Term Post-COVID Complications and Repurposing of Drugs
    Majumder, Rajib
    Ghosh, Sanmitra
    Singh, Manoj K.
    Das, Arpita
    Roy Chowdhury, Swagata
    Saha, Abinit
    Saha, Rudra P.
    COVID, 2023, 3 (04): : 494 - 519
  • [10] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    CLINICAL LABORATORY, 2022, 68 (02) : 291 - 297